Nordea Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-93,613
Closed -$1.45M 1030
2017
Q2
$1.45M Buy
+93,613
New +$1.45M ﹤0.01% 749